Oral Oncolytics: Leukemia Market

Chapter 2  provides an executive summary of the insights captured in our research. The summary offers a high level view on the likely evolution of oral targeted leukemia market.

Chapter 3  provides a general introduction to leukemia. We have discussed, in detail, about types of leukemia, common signs and symptoms, its occurrence / prevalence and the current treatment regimes.

Table of Contents

1. PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.3. Chapter Outlines

List of Figuers

Figure 3.1 Leukemia: Incidence Rate in the US (2013)
Figure 3.2 Leukemia: Incidence Rate in the US by Age Group (2006 – 2010)

List of Tables

Table 4.1 List of Approved Targeted Drugs for ALL, 2013
Table 4.2 List of Approved Targeted Drugs for CLL, 2013

Listed Companies

Please reach out to our team for the details.